Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
MAP4K3/GLK: Structure, molecular pharmacology and drug development
Jingwen Wang
, Xiaoe Yan
, Haibo Li
, Yudao Shen
, Caihong Yun
, Jianming Zhang
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MAP4K3/GLK: Structure, molecular pharmacology and drug development'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Signaling Pathway
100%
Drug Development
100%
Macromolecular Drugs
100%
Molecular Pharmacology
100%
MAP3K4
100%
Aging
50%
Immune Response
50%
Small Molecule Inhibitors
50%
Novel Therapeutics
50%
Therapeutic Intervention
50%
NF-B
50%
Mammalian Target of Rapamycin (mTOR)
50%
Molecular Targets
50%
Autoimmune Disease
50%
Human Disease
50%
Serine-threonine Kinase
50%
COVID-19 Infection
50%
Gene Regulatory Network
50%
Cell Signaling Pathways
50%
Protein Kinase Structure
50%
MAP4K4
50%
Oncotherapy
50%
Biochemistry, Genetics and Molecular Biology
Autoimmunity
100%
Protein Kinases
100%
Kinase
100%
Phosphotransferase
100%
Small Molecule
100%
T Cell Receptor
100%
Immune Response
100%
Regulatory Network
100%
Mammalian Target of Rapamycin
100%
Chemical Structure
100%
Serine
100%
Threonine
100%
Drug Development
100%
Immunology and Microbiology
COVID-19
100%
Immunotherapy
100%
T Cell Receptor
100%
Autoimmune Disease
100%
Immune Response
100%
Chemical Structure
100%
Serine
100%
Threonine
100%
Infection
100%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Development
100%
Molecular Pharmacology
100%
Diseases
100%
Malignant Neoplasm
50%
Immunotherapy
50%
Infection
50%
Protein Serine Threonine Kinase
50%
Autoimmune Disease
50%
Molecular Target
50%
Protein Kinases
50%